Meningitis, Meningococcal Clinical Trial
Official title:
A Randomized, Single-blind, Placebo-controlled, Phase 2 Trial Of The Safety, Immunogenicity, And Tolerability Of Meningococcal Serogroup B (Mnb) Rlp2086 Vaccine At Doses Of 60 Mug, 120 Mug, And 200 Mug In Healthy Adolescents Aged 11 To 18 Years
The purpose of this study is to evaluate the safety and immunogenicity of an investigational meningococcal B rLP2086 vaccine in adolescents aged 11 to 18 years old.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04689191 -
A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine
|
Phase 3 | |
| Recruiting |
NCT04689165 -
A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine
|
Phase 3 | |
| Completed |
NCT00780806 -
Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults
|
Phase 1/Phase 2 | |
| Completed |
NCT03378258 -
Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.
|
||
| Completed |
NCT03205371 -
Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers
|
Phase 3 | |
| Completed |
NCT01352793 -
A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
|
Phase 3 | |
| Not yet recruiting |
NCT06113198 -
A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age
|
Phase 4 | |
| Completed |
NCT03295318 -
Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds
|
Phase 2 | |
| Completed |
NCT03493919 -
A Sourcing Study to Collect Human Blood Samples From Healthy Adults
|
Phase 4 | |
| Completed |
NCT00474526 -
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
|
Phase 3 | |
| Completed |
NCT00297687 -
Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults
|
Phase 1 | |
| Recruiting |
NCT04665791 -
A Human Controlled Infection Study With Neisseria Lactamica in Malian Adults
|
N/A | |
| Withdrawn |
NCT03431675 -
Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018
|
Phase 4 | |
| Recruiting |
NCT02878291 -
Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months
|
Phase 1 | |
| Completed |
NCT00314041 -
Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants
|
Phase 2 | |
| Recruiting |
NCT04685850 -
Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans
|
||
| Completed |
NCT03587207 -
Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years
|
Phase 2 | |
| Completed |
NCT03824093 -
High and Low Resource Interventions to Promote HPV Vaccines
|
N/A | |
| Completed |
NCT04707391 -
Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine
|
Phase 3 | |
| Terminated |
NCT00798304 -
Study Evaluating Safety, Tolerability, and Immunogenicity of Meningococcal B Vaccine in Healthy Infants
|
Phase 2 |